Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum.
Nutr Cancer
; 61(1): 16-26, 2009.
Article
em En
| MEDLINE
| ID: mdl-19116872
ABSTRACT
Prostate cancer (PCa) is the most common male malignancy in many Western countries. Primary PCa is hormone dependent and is manageable by hormonal therapy. However, it rapidly develops to hormone-refractory tumors due to the accumulation of mutations in the androgen receptor and/or the acquisition of alternative cellular pathways that support proliferation and inhibit apoptosis of prostate cancer. To date, no effective therapy is available for clinically hormone-insensitive or hormone-refractory stages of prostate cancer.
Texto completo:
1
Base de dados:
MEDLINE
Métodos Terapêuticos e Terapias MTCI:
Plantas_medicinales
Assunto principal:
Neoplasias da Próstata
/
Reishi
/
Neoplasias Hormônio-Dependentes
/
Antineoplásicos
Idioma:
En
Revista:
Nutr Cancer
Ano de publicação:
2009
Tipo de documento:
Article
País de afiliação:
Israel